Dear Colleague,
I would like to invite you to please consider participating in the GlobalSurg-CovidSurg Week study.
Study key points:
>All surgical/ anaesthetic teams can participate: the study is open to all surgical specialties, including obstetrics.
>All hospitals worldwide can participate: study is open for all countries (you do not need to have operated on SARS-CoV-2 patients).
>Short data collection window: collaborators will collect data on all patients operated by their specialty over a 7-day block in October 2020.
>Inclusive study authorship: all collaborators who submit data will be recognised as PubMed-citable co-authors; please see our Lancet paper for an example (click “expand” under ‘COVIDSurg Collaborative’ to see a full list of co-authors).
Earlier this year our collaborative has run two studies, CovidSurg and CovidSurg-Cancer, which collected data on over40,000 patients from 1,020 hospitals in 85 countries. Our first paper was published in The Lancet (all contributors listed as co-authors). It demonstrated that patients who undergo surgery with perioperative SARS-CoV-2 are at high risk of pulmonary complications and death.
GlobalSurg-CovidSurg Week has two aims:
>To determining the optimal timing for surgery in patients who were previously infected with SARS-CoV-2.
>To determine key global surgical indicators, such as perioperative mortality rates, surgical volume, surgical case-mix. We are keen to work with collaborators from all types of hospital (rural hospitals, district hospitals, private hospitals, university hospitals) across all countries. You can participate even if your hospital has not treated SARS-CoV-2 infected patients.
A graphic summary is available online. Please find attached the study protocol (UK centres should register this as clinical audit). Template patient information sheets and consent forms can be found on our website.
Please register your interest in taking part using our online form at https://globalsurgery.redcap.bham.ac.uk/surveys/index.php?s=ERAME4NJHR.
Thank you very much for your time.
Best wishes
Ewen Griffiths
yes this is study is good one and i am looking forward to part of it. thank you
We wanted to be a part of this study, but I guess we were late. Is there any way to include us as a major referral hospital? Sincerely,
Ramazan SARI, General Surgeon, MD